MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202641085464 A) filed by Kalasalingam Academy Of Research And Education on July 13, 2026, for Liquid Biopsy Based System For Detection Of Autism Related Metabolic And Protemic Signatures.
Inventors include V. Krishnamoorthy; Dr. T. Arunprasath; and Dr. M. Pallikonda Rajasekaran.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: ABSTRACT 5 Title: LIQUID BIOPSY-BASED SYSTEM FOR DETECTION OF AUTISM-RELATED METABOLIC AND PROTEOMIC SIGNATURES 10 15 This invention relates to a liquid biopsy-based system for detection of autism-related metabolic and proteomic signatures. It typically includes a Sample Collection Module (1), a Microfluidic Sample Processing Module (2), a Biosensing and Analytical Module ,(3) a Biomarker Detection Module (4), a Machine Learning Engine (5), an Explainable Al (XAl) Module (6), a Cloud Database Module (7), and a Report Generation Module (8).This system provides a minimally invasive, objective, and highly sensitive diagnostic solution that streamlines ASD screening and therapy monitoring by integrating automated microfluidic sample processing with Al-driven multi-omics analysis. This system serves as a versatile diagnostic platform for facilitating early, objective ASD screening, enabling longitudinal therapy monitoring, and providing precise, data-driven insights to support personalized treatment plans for neurodevelopmental conditions.
Disclaimer: Curated by HT Syndication.
